Detalhe da pesquisa
1.
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways.
J Transl Med
; 21(1): 271, 2023 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081509
2.
A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection.
J Med Virol
; 95(1): e28105, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045503
3.
COVID-19 Vaccines-All You Want to Know.
Semin Respir Crit Care Med
; 44(1): 143-172, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36646092
4.
Increased risk of severe COVID-19 in pregnancy in a multicenter propensity score-matched study.
J Perinat Med
; 51(9): 1171-1178, 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596826
5.
Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease.
Clin Infect Dis
; 74(7): 1279-1283, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34420052
6.
Short-duration treatment with the novel non-nucleoside inhibitor CDI-31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open-label study.
J Med Virol
; 93(6): 3752-3760, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150966
7.
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
Int J Mol Sci
; 22(11)2021 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071064
8.
A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY).
J Hepatol
; 71(3): 498-504, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173815
9.
COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.
J Gen Intern Med
; 35(11): 3359-3360, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885370
10.
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects.
Microorganisms
; 12(3)2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543650
11.
Are Biodegradable Calcium Sulfate Antibiotic Beads Effective and Safe Adjuvants for Diabetic Foot Osteomyelitis?
Cureus
; 16(1): e52444, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38371037
12.
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trial.
Lancet Infect Dis
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679035
13.
A rare case of Sphingomonas paucimobilis ventriculitis.
Germs
; 13(3): 254-258, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146376
14.
A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains.
Microorganisms
; 11(6)2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37375051
15.
Immune-Mediated Pathogenesis in Dengue Virus Infection.
Viruses
; 14(11)2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423184
16.
Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays.
Methods Mol Biol
; 2409: 271-289, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709649
17.
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection.
AIDS
; 36(3): 399-407, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750294
18.
Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Infect Dis
; 22(5): 611-621, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286843
19.
Campylobacter fetus aortitis in a patient with HIV.
IDCases
; 25: e01169, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34094867
20.
Evolution of Nipah Virus Infection: Past, Present, and Future Considerations.
Trop Med Infect Dis
; 6(1)2021 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33672796